Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
2016 · Biomaterials · 357 citations
https://doi.org/10.1016/j.biomaterials.2016.09.031
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
2.9K
Citations
20
h-index
25
i10-index
Masaki Morishita is an academic researcher from Kobe Pharmaceutical University. The author has contributed to research in topics: Extracellular vesicles in disease & RNA Interference and Gene Delivery & MicroRNA in disease regulation. The author has an h-index of 20, co-authored 41 publications.
ORCID: 0000-0002-3004-3779https://doi.org/10.1016/j.biomaterials.2016.09.031
https://doi.org/10.1016/j.xphs.2018.07.011
Click to start Chat